Takasago, Japan

Hiroyuki Kanamaru



Average Co-Inventor Count = 4.1

ph-index = 1


Location History:

  • Hyogo, JP (2016)
  • Takasago, JP (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hiroyuki Kanamaru: Innovator in Recombinant Protein Production

Introduction

Hiroyuki Kanamaru is a notable inventor based in Takasago, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 5 patents to his name, Kanamaru's work has advanced the methods used in protein synthesis.

Latest Patents

One of Kanamaru's latest patents is a method for producing recombinant proteins using recombinant Brevibacillus. This invention enhances the cell growth rate during culture while ensuring stable maintenance of plasmids, ultimately improving the yield of recombinant proteins. The method involves a high-temperature culture step at 32°C or higher, followed by a low-temperature culture step below 32°C. Another significant patent focuses on a vector, a transformant, and a method to produce a polypeptide that selectively hydrolyzes a (R)-tropic acid amide in a racemic mixture. This invention aims to produce optically active tropic acid, which is valuable as a synthetic raw material or an intermediate for pharmaceutical products.

Career Highlights

Hiroyuki Kanamaru is currently employed at Kaneka Corporation, where he continues to innovate in the field of biotechnology. His work has not only contributed to the scientific community but has also had practical applications in various industries.

Collaborations

Kanamaru has collaborated with notable coworkers such as Makoto Ueda and Yoshihiko Yasohara. Their combined expertise has furthered the advancements in the technologies they are developing.

Conclusion

Hiroyuki Kanamaru's contributions to recombinant protein production exemplify the impact of innovative thinking in biotechnology. His patents reflect a commitment to enhancing methods that benefit both science and industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…